Beijing Pinggu District Hospital
10
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Wearable ECG for AF Screening and Stroke Risk Assessment
Role: collaborator
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
Role: collaborator
Effect and Safety of Surgical Intervention for Severe Spontaneous Intracerebral Hemorrhage Patients on Long-term Oral Antiplatelet Treatment
Role: collaborator
COVID-19 Infection and Idiopathic Membranous Nephropathy
Role: collaborator
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)
Role: collaborator
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)
Role: collaborator
Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE
Role: collaborator
Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression
Role: collaborator
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Role: collaborator
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
Role: collaborator
All 10 trials loaded